Research Article

Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study

Table 3

Diagnostic efficiency of various variables for HCC.

VariableOptimal cut-off valueSEN%SPE%AUC95% CI

AFP (ng/mL)>4.9556.8689.190.7330.691-0.772<0.001
CA19-9 (U/mL)>38.850.9884.050.7000.656-0.741<0.001
CA12-5 (U/mL)>10.490.2046.220.7420.700-0.781<0.001
CEA (ng/mL)>2.5766.6754.590.5950.549-0.6400.002
AFP+CA19-9+CA12-5+CEA>0.176362.7584.050.7720.732-0.809<0.001
ssDNA (ng/μL)>12.3695.1076.490.9090.879-0.933<0.001
AFP+CA199>0.182464.0884.280.7710.730-0.808<0.001
AFP+CA125>0.189166.9974.530.7710.730-0.808<0.001
AFP+CEA>0.201054.3781.300.7100.667-0.751<0.001
CA199+CA125>00.00100.000.5000.454-0.546<0.001
CA199+CEA>0.1927971.8461.520.7050.662-0.746<0.001
CA125+CEA>0.2072547.5788.890.7360.694-0.775<0.001
AFP+CA199+CEA>0.18560.1986.990.7770.736-0.813<0.001
AFP+CA199+CA125>0.1761366.0282.110.7830.743-0.819<0.001
CA199+CA125+CEA>0.1843259.2282.380.7510.710-0.790<0.001
ssDNA+AFP+CA199>0.1606587.3881.300.9020.872-0.927<0.001
ssDNA+AFP+CA125>0.166985.4483.470.9050.875-0.930<0.001
ssDNA+AFP+CEA>0.1514493.2078.050.9070.877-0.932<0.001
ssDNA+CA199+CA125>0.1660884.4782.660.9000.869-0.925<0.001
ssDNA+CA199+CEA>0.1704385.4483.470.9000.869-0.925<0.001
ssDNA+CA125+CEA>0.1786783.5085.910.9050.875-0.930<0.001
ssDNA+AFP+CA199+CA125>0.1539389.3278.860.9020.872-0.927<0.001
ssDNA+AFP+CA199+CEA>0.1652286.4183.470.9010.871-0.927<0.001
ssDNA+CA199+CA125+CEA>0.1615387.3881.570.9010.870-0.926<0.001
ssDNA+AFP>0.144895.1076.490.9110.882-0.935<0.001
ssDNA+CA19-9>0.143395.1074.590.9040.874-0.929<0.001
ssDNA+CA12-5>0.153390.2078.650.9060.876-0.931<0.001
ssDNA+CEA>0.152994.1278.380.9090.880-0.934<0.001
ssDNA+AFP+CA19-9+CA12-5+CEA>0.155589.2281.890.9050.875-0.930<0.001

AFP: alpha-fetoprotein; CA: cancer antigen; CEA: carcinoembryonic antigen; ssDNA: single-stranded DNA; SEN: sensitivity; SPE: specificity; AUC: area under the curve; CI: confidence interval.